Suchergebnisse - "Breccia, Massimo"

PubPharm (81)

1

Novel tyrosine-kinase inhibitors for the treatment of chronic myeloid leukemia : safety and efficacy

enthalten in: Expert review of hematology | 2018

von Massaro, F. | Colafigli, G. | Molica, M. | +1

2

Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib : Long-term 9-year follow-up of 134 patients

enthalten in: American journal of hematology | 2015

von Breccia, M. | Latagliata, R. | Molica, M. | +5

3

Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib

enthalten in: American journal of hematology | 2015

von Latagliata, R. | Volpicelli, P. | Breccia, M. | +11

4

The Importance of Body Surface Area at Baseline and during Treatment in Chronic Myeloid Leukemia Patients Treated with Imatinib

enthalten in: Acta haematologica | 2015

von Breccia, M. | Molica, M. | Colafigli, G. | +1

5

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival

enthalten in: Leukemia research | 2014

von Breccia, M. | Luciano, L. | Latagliata, R. | +33

CommentIn: Leuk Res. 2014 Oct;38(10):1156-7. - PMID 25113280

6

Discontinuation of tyrosine kinase inhibitors and new approaches to target leukemic stem cells : treatment-free remission as a new goal in chronic myeloid leukemia

enthalten in: Cancer letters | 2014

von Breccia, M. | Alimena, G.

7

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients : the EORTC QLQ-CML24

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2014

von Efficace, F. | Baccarani, M. | Breccia, M. | +19

8

Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitors

enthalten in: Leukemia research | 2014

von Efficace, F. | Rosti, G. | Cottone, F. | +5

9

Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib

enthalten in: Leukemia & lymphoma | 2014

von Breccia, M. | Salaroli, A. | Serrao, A. | +3

10

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era

enthalten in: American journal of hematology | 2014

von Malagola, M. | Breccia, M. | Skert, C. | +29

1
2
3
4
5
6
7
8
9
Nächster »
[9]